Podcast TCTMD Talking Points MITRAL: 30-Day Outcomes of Transcatheter MV Replacement in Severe MV Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings Mayra Guerrero sits down with C. Michael Gibson to discuss the MITRAL trial approaches.
Podcast TCTMD Talking Points ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease C. Michael Gibson gets the full story from Rasha Al-Lamee on one of the most talked about trials of 2017.
Podcast TCTMD Talking Points CULPRIT-SHOCK: A Randomized Trial of Multivessel PCI in Cardiogenic Shock Holger Thiele reviews the CULPRIT-SHOCK trial and its findings with C. Michael Gibson.
Podcast TCTMD Talking Points Robotic PCI in Practice and Training C. Michael Gibson talks with Manish Parikh about robotic PCI technology.
Podcast TCTMD Talking Points VAMPIRE 3: A Randomized Trial of Distal Filter Protection During PCI of High-Risk Plaque New Japanese data from VAMPIRE 3 hints that filter protection during high-risk PCI may still have a role.
Podcast TCTMD Talking Points SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients Older Than 75 Years Olivier Varenne sits down with C. Michael Gibson to discuss the SENIOR results of a bioabsorbable polymer-based metallic DES.
Podcast TCTMD Talking Points PREVAIL: 5-Year Outcomes Following Left Atrial Appendage Closure in Patients With Non-Valvular Atrial Fibrillation C. Michael Gibson asks Vivek Y. Reddy about the 5-year outcomes in patients who underwent LAA closure with the Watchman device.
Podcast TCTMD Talking Points FORMA: 30-Day Outcomes of Transcatheter TV Repair in Patients With Severe Regurgitation C. Michael Gibson gets the details on FORMA from Susheel Kodali.
Podcast TCTMD Talking Points Switching Antiplatelet Therapy: New International Consensus Dominick Angiolillo walks C. Michael Gibson through a new consensus document regarding switching and bridging of P2Y12 inhibitors
Podcast TCTMD Talking Points TRACER: 6-Month Outcomes of Transcatheter MV Neochordal Repair in Patients With Severe Primary MR C. Michael Gibson gets the details on TRACER from James Gammie.